Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferdinando Squitieri

Showing results (131-140 of 147) with videos related to

Pageof 15
Sort By:
Journal of Neurology|June 11, 2026
Development and validation of the first needs-based quality of life measure for individuals with manifest Huntington's diseaseIsobel Spray, Mariusz T Grzeda, Jeanette Thorpe, et al.
Cell Death & Disease|October 16, 2020
Sorcin is an early marker of neurodegeneration, Ca<sup>2+</sup> dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseasesIlaria Genovese, Flavia Giamogante, Lucia Barazzuol, et al.
Nature Medicine|September 5, 2025
Pridopidine in early-stage manifest Huntington's disease: a phase 3 trialRalf Reilmann, Andrew Feigin, Anne E Rosser, et al.
Scientific Reports|July 13, 2017
Polyglutamine expansion affects huntingtin conformation in multiple Huntington's disease modelsManuel Daldin, Valentina Fodale, Cristina Cariulo, et al.
Science (New York, N.Y.)|November 26, 2002
Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonismVincenzo Bonifati, Patrizia Rizzu, Marijke J van Baren, et al.
American Journal of Human Genetics|May 21, 2019
Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington DiseaseGalen E B Wright, Jennifer A Collins, Chris Kay, et al.
Journal of Personalized Medicine|August 27, 2021
Perceptions about Research Participation among Individuals at Risk and Individuals with Premanifest Huntington's Disease: A Survey Conducted by the European Huntington AssociationFilipa Júlio, Ruth Blanco, Josè Perez Casanova, et al.
Journal of Neurology|February 8, 2020
Utility of the Parkinson's disease-Cognitive Rating Scale for the screening of global cognitive status in Huntington's diseaseSaul Martinez-Horta, Andrea Horta-Barba, Jesús Perez-Perez, et al.
Journal of Neurology|January 5, 2021
Correction to: Utility of the Parkinson's disease-Cognitive Rating Scale for the screening of global cognitive status in Huntington's diseaseSaul Martinez-Horta, Andrea Horta-Barba, Jesús Perez-Perez, et al.
Journal of Huntington'S Disease|October 4, 2021
Arithmetic Word-Problem Solving as Cognitive Marker of Progression in Pre-Manifest and Manifest Huntington's DiseaseAndrea Horta-Barba, Saul Martinez-Horta, Jesús Perez-Perez, et al.
Pageof 15

Showing results (131-140 of 147) with videos related to

Sort By:
Pageof 15
Journal of Neurology|June 11, 2026
Development and validation of the first needs-based quality of life measure for individuals with manifest Huntington's diseaseIsobel Spray, Mariusz T Grzeda, Jeanette Thorpe, et al.
Cell Death & Disease|October 16, 2020
Sorcin is an early marker of neurodegeneration, Ca<sup>2+</sup> dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseasesIlaria Genovese, Flavia Giamogante, Lucia Barazzuol, et al.
Nature Medicine|September 5, 2025
Pridopidine in early-stage manifest Huntington's disease: a phase 3 trialRalf Reilmann, Andrew Feigin, Anne E Rosser, et al.
Scientific Reports|July 13, 2017
Polyglutamine expansion affects huntingtin conformation in multiple Huntington's disease modelsManuel Daldin, Valentina Fodale, Cristina Cariulo, et al.
Science (New York, N.Y.)|November 26, 2002
Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonismVincenzo Bonifati, Patrizia Rizzu, Marijke J van Baren, et al.
American Journal of Human Genetics|May 21, 2019
Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington DiseaseGalen E B Wright, Jennifer A Collins, Chris Kay, et al.
Journal of Personalized Medicine|August 27, 2021
Perceptions about Research Participation among Individuals at Risk and Individuals with Premanifest Huntington's Disease: A Survey Conducted by the European Huntington AssociationFilipa Júlio, Ruth Blanco, Josè Perez Casanova, et al.
Journal of Neurology|February 8, 2020
Utility of the Parkinson's disease-Cognitive Rating Scale for the screening of global cognitive status in Huntington's diseaseSaul Martinez-Horta, Andrea Horta-Barba, Jesús Perez-Perez, et al.
Journal of Neurology|January 5, 2021
Correction to: Utility of the Parkinson's disease-Cognitive Rating Scale for the screening of global cognitive status in Huntington's diseaseSaul Martinez-Horta, Andrea Horta-Barba, Jesús Perez-Perez, et al.
Journal of Huntington'S Disease|October 4, 2021
Arithmetic Word-Problem Solving as Cognitive Marker of Progression in Pre-Manifest and Manifest Huntington's DiseaseAndrea Horta-Barba, Saul Martinez-Horta, Jesús Perez-Perez, et al.
Pageof 15